Breast cancer, which exhibits an increasing incidence and high mortality rate among
cancers, is predominantly attributed to metastatic malignancies. Brain metastasis, in …

Metastatic spread of tumour cells to tissues and organs around the body is the most frequent
cause of death from breast cancer. This has been modelled mainly using mouse models …

Breast cancer (BC) brain metastases (BCBM) is a severe condition frequently occurring in
the triple-negative subtype. The study of BCBM pathogenesis and treatment has been …

Simple Summary There is paucity of data on the optimal management of brain metastases in
older women≥ 65 years old with breast cancer. In this single-institutional retrospective …

Background. Breast cancer is an important cause of cancer‐related death in women
worldwide and represents the second most frequent cause of brain metastases after lung …

The incidence of brain metastases (BM) amongst cancer patients has been increasing due
to improvements in therapeutic options and an increase in overall survival. Molecular …

Objective Our purpose was to describe our initial institutional experience using dedicated
brain [18F]-Fluoroestradiol (FES) PET/CT or PET/MRI in the management of patients with …

This review explores the resistance of breast cancer brain metastases to trastuzumab
therapy, particularly in HER2-positive cases. Breast cancer is one of the most commonly …

The sub-types of breast cancer such as triple-negative and HER2+ patients have 50%
chances of developing brain metastasis at stage IV of their cancer progression and have …

Background: Triple-negative breast cancer (TNBC) is a particularly aggressive subtype of
cancer, characterized by its high propensity for metastasis. Patients who experience the …